New Strategies in the Development of Antimicrobial Coatings: The Example of Increasing Usage of Silver and Silver Nanoparticles
Tóm tắt
Bacterial infection from medical devices is a major problem and accounts for an increasing number of deaths as well as high medical costs. Many different strategies have been developed to decrease the incidence of medical device related infection. One way to prevent infection is by modifying the surface of the devices in such a way that no bacterial adhesion can occur. This requires modification of the complete surface with, mostly, hydrophilic polymeric surface coatings. These materials are designed to be non-fouling, meaning that protein adsorption and subsequent microbial adhesion are minimized. Incorporation of antimicrobial agents in the bulk material or as a surface coating has been considered a viable alternative for systemic application of antibiotics. However, the manifestation of more and more multi-drug resistant bacterial strains restrains the use of antibiotics in a preventive strategy. The application of silver nanoparticles on the surface of medical devices has been used to prevent bacterial adhesion and subsequent biofilm formation. The nanoparticles are either deposited directly on the device surface, or applied in a polymeric surface coating. The silver is slowly released from the surface, thereby killing the bacteria present near the surface. In the last decade there has been a surplus of studies applying the concept of silver nanoparticles as an antimicrobial agent on a range of different medical devices. The main problem however is that the exact antimicrobial mechanism of silver remains unclear. Additionally, the antimicrobial efficacy of silver on medical devices varies to a great extent. Here we will review existing antimicrobial coating strategies and discuss the use of silver or silver nanoparticles on surfaces that are designed to prevent medical device related infections.
Từ khóa
Tài liệu tham khảo
Gradinger, 2008, Das infizierte implantat, Der. Orthopäde, 3, 257
Hellmann, 2010, The estimated magnitude and direct hospital costs of prosthetic joint infections in the United States, 1997 to 2004, J. Athroplasty, 25, 766, 10.1016/j.arth.2009.05.025
Sampredo, 2007, Infections associated with long-term prosthetic devices, Infect. Dis. Clin. N. Am., 21, 785, 10.1016/j.idc.2007.07.001
Tokarczyk, 2009, Death, dollars, and diligence: Prevention of catheter-related bloodstream infections must persist, Crit. Care Med., 37, 2320, 10.1097/CCM.0b013e3181a9efa9
jansen, 2005, Infections associated with medical devices, Drugs, 65, 179, 10.2165/00003495-200565020-00003
Turnidge, 2009, Staphylococcus aureus bacterimia: A major cause of mortality in Australia and New Zealand, Med. J. Aust., 191, 368, 10.5694/j.1326-5377.2009.tb02841.x
Olsen, 2008, Horpital-associated costs due to surgical site infection after breast surgery, Arch. Surg., 143, 53, 10.1001/archsurg.2007.11
Noimark, 2009, The role of surfaces in catheter-associated infections, Chem. Soc. Rev., 38, 3435, 10.1039/b908260c
Trautner, 2004, Catheter-associated infections, Arch. Intern. Med., 164, 842, 10.1001/archinte.164.8.842
David, 2005, Central venous catheters and infections, Minerva Anestesiol., 71, 561
Halton, 2007, Economic evaluation and catheter-related bloodstream infections, Emerg. Infect. Dis., 13, 815, 10.3201/eid1306.070048
Prencevich, 2009, Preventing catheter-related bloodstream infections, J. Am. Med. Assoc., 301, 1285, 10.1001/jama.2009.420
Moureau, 2009, Reducing the costs of catheter-related bloodstream infections, Nursing, 39, 14, 10.1097/01.NURSE.0000357259.58840.eb
Zingg, 2009, Impact of a prevention strategy targeting hand hygiene and catheter care on the incidence of catheter-related bloodstream infections, Crit. Care Med., 37, 2167, 10.1097/CCM.0b013e3181a02d8f
Kallen, 2010, Preventing catheter-related bloodstream infections outside the intensive care unit: Expanding to new settings, Healthcare Epidem., 51, 335
Walz, 1997, Prevention of central venous catheter bloodstream infections, J. Intensive Care Med., 25, 131, 10.1177/0885066609358952
Rosenthal, 2008, The international nosocomical infection control consortium (INICC): Goals and objectives, description of surveillance methods, and operational activities, Am. J. Infect. Control, 36, e1, 10.1016/j.ajic.2008.06.003
Bearman, 2006, Infection control and the prevention of nosocomical infections in the intensive care unit, Sem. Resp. Crit. Care Med., 27, 310, 10.1055/s-2006-945534
Youg, 2006, How to respond to changes in the regulation of the ethylene-oxide sterilization process, Med. Dev. Technol., 17, 12
Thevenot, 2008, Surface chemistry influences implant biocompatibility, Curr. Top. Med. Chem., 8, 270, 10.2174/156802608783790901
Vroman, 1987, Methods of investigating protein interactions on artificial and natural surfaces, Ann. N. Y. Acad. Sci., 516, 300, 10.1111/j.1749-6632.1987.tb33050.x
Stutz, 2009, Protein attachment onto silica surfaces—A survey of molecular fundamentals, resulting effects and novel preventive strategies in CE, Electrophoresis, 30, 2032, 10.1002/elps.200900015
Fang, 2001, Kinetics and thermodynamics of protein adsorption: A generalized molecular theoretical approach, Biophys. J., 80, 2568, 10.1016/S0006-3495(01)76228-5
Ganazzoli, 2005, Computer simulation of polypeptide adsorption on model biomaterials, Phys. Chem. Chem. Phys., 7, 365, 10.1039/b506813d
Pavithra, 2008, Biofilm formation, bacterial adhesion and host response on polymeric implants—issues and prevention, Biomed. Mater., 3, 1, 10.1088/1748-6041/3/3/034003
Hoiby, 2010, Antibiotic resistance of bacterial biofilms, Int. J. Antimicrob. Agents, 35, 322, 10.1016/j.ijantimicag.2009.12.011
Stoodley, 2009, Evolving concepts in biofilm infections, Cell. Microbiol., 11, 1034, 10.1111/j.1462-5822.2009.01323.x
Donlan, 2002, Biofilms: Microbial life on surfaces, Emerg. Infect. Dis., 9, 891
Sutherland, 2001, The biofilm matrix—an immobilized but dynamic microbial environment, Trends Microbiol., 9, 222, 10.1016/S0966-842X(01)02012-1
Sousa, C., Teixeira, P., and Oliveira, R. (2009). Influence of surface properties on the adhesion of Staphylococcus epidemidis to acrylic and silicone. Int. J. Biomater.
Busscher, 1997, The influence of calcium on the initial adhesion of S. thermophilus to stainless steel under flow studied by metallurgical microscopy, Biofouling, 11, 167, 10.1080/08927019709378327
Katsikogianni, 2006, Adhseion of slime producing Staphylococcus epidermidis strains to PVC and diamond-like carbon/silver/fluorinated coatings, J. Mater. Sci., 17, 679
Rodil, 2010, Oral bacterial adhesion on amorphous carbon and titanium films: Effect of surface roughness and culture media, J. Biomed. Mater. Sci. B Appl. Biomater., 92B, 196, 10.1002/jbm.b.31506
Zhao, 2000, Polymeric brushes: Surface-immobilized macromolecules, Prog. Polym. Sci., 25, 677, 10.1016/S0079-6700(00)00012-5
Hoffmann, 2006, Blood cell and plasma protein repellent properties of star-PEG-modified surfaces, J. Biomater. Sci. Polym. Ed., 17, 985, 10.1163/156856206778366059
Fundeanu, 2010, Solvent-free functionalization of silicone rubber and efficacy of PAAm brushes grafted from an amino-PPX layer against bacterial adhesion, Acta Biomater., 6, 4271, 10.1016/j.actbio.2010.06.010
Cheng, 2008, A switchable biocompatible polymer surface with self-sterilizing and nonfouling capabilities, Angew. Chem. Int. Ed., 47, 8831, 10.1002/anie.200803570
Senaratne, 2005, Self-assembled monolayers and polymer brushes in biotechnology: Current applications and future perspectives, Biomacromolecules, 6, 2427, 10.1021/bm050180a
Schreiber, 2000, Structure and growth of self-assembling monolayers, Prog. Surf. Sci., 65, 151, 10.1016/S0079-6816(00)00024-1
Bearinger, 2003, Chemiadsorbed poly(propylene sulphide)-based copolymers resist biomolecular interactions, Nat. Mater., 2, 259, 10.1038/nmat851
Khoo, 2009, Directed assembly of PEGylated-peptide coatings for infection-resistant titanium metal, J. Am. Chem. Soc., 131, 10992, 10.1021/ja9020827
Heijkants, 2006, Nanotechnology delivers microcoatings, Med. Device Technol., 17, 14
Bridges, 2008, Anti-inflammatory polymeric coatings for implantable biomaterials and devices, J. Diabet. Sci. Technol., 2, 984, 10.1177/193229680800200628
Roosjen, 2004, Microbial adhesion to poly(ethyle oxide) brushes: Influence of polymer chain length and temperature, Langmuir, 20, 10949, 10.1021/la048469l
Nohr, 1994, New biomaterials through surface segregation phenomenon: New quaternary ammonium compounds as antibacterial agents, J. Bioamter. Sci. Polym. Ed., 5, 607, 10.1163/156856294X00239
Thorsteinsson, 2003, Soft antibacterial agents, Curr. Med. Chem., 10, 1129, 10.2174/0929867033457520
Murata, 2007, Permanent, non-leaching antibacterial surfaces-2: How high density cationic surfaces kill bacterial cells, Biomaterials, 28, 4870, 10.1016/j.biomaterials.2007.06.012
Cheng, 2010, Integrated antimicrobial and nonfouling hydrogels to inhibit the growth of planktonic bacterial cells and keep the surface clean, Langmuir, 26, 10425, 10.1021/la101542m
Rawlinson, 2010, High content analysis of cytotoxic effects of pDMAEMA on human intestinal epithelial and monocytes cultures, J. Contr. Rel., 146, 84, 10.1016/j.jconrel.2010.05.002
Venkataraman, 2010, Design, synthesis and evaluation of hemocompatible pegylated-antimcrobial polymers with well-controlled molecular structures, Biomaterials, 31, 1751, 10.1016/j.biomaterials.2009.11.030
Cross, J., and Singer, E.J. (1990). Cationic Surfactants, Marcel Dekker Inc. [1st ed.].
Ravikumar, 2006, Surface-active antifungal polyqyaternary amine, Biomacromolecules, 7, 2762, 10.1021/bm060476w
Hegstad, 2010, Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health?, Microb. Drug Resist., 16, 91, 10.1089/mdr.2009.0120
Russell, 2002, Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria, J. Appl. Microbiol., 92, 121S, 10.1046/j.1365-2672.92.5s1.12.x
Fleming, 1929, On the antibacterial action of cultures of a Penicilium, with special reference to their use in the isolation of B. influenzae, Br. J. Exp. Pathol., 10, 226
Jaeblon, 2010, Polymethylmethacrylate: Properties and contemporary uses in orhtopaedics, J. Am. Acad. Otrhop. Surg., 18, 297, 10.5435/00124635-201005000-00006
Webb, 2007, The role of polymethylmethacrylate bone cement in modern orthopaedic surgery, J. Bone Joint Surg., 89-B, 851, 10.1302/0301-620X.89B7.19148
Norowski, 2009, Biomaterial and antibiotic strategies for peri-implants, J. Biomed. Mater. Res. B Appl. Biomater., 88B, 530, 10.1002/jbm.b.31152
Zhao, 2009, Antibacterial coatings on titanium implants, J. Biomed. Mater. Res. B Appl. Biomater., 91B, 470, 10.1002/jbm.b.31463
Schierholz, 2006, Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: An in vitro and in vivo study, J. Orthop. Res., 24, 1622, 10.1002/jor.20193
Harris, 2006, Bacteria and cell cytocompatibility studies on coated medical grade titanium surfaces, J. Biomed. Mater. Res., 78A, 50, 10.1002/jbm.a.30611
Oosterbos, 2002, Osseointegration of hydroxyapatite-coated and noncoated Ti6Al4V implants in the presence of local infection: A comparative histomorphometrical study in rabbits, J. Biomed. Mater. Res., 60, 339, 10.1002/jbm.1288
Stigter, 2002, Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium, Biomaterials, 23, 4143, 10.1016/S0142-9612(02)00157-6
Stigter, 2004, Incorporation of different antibiotics into carbonated hydrozyapatite coatings on titanium implants, release and antibiotic effect, J. Contr. Rel., 99, 127, 10.1016/j.jconrel.2004.06.011
Darouiche, 2007, In vivo efficacy of antimicrobial-coated devices, J. Bone Joint Surg. Am., 89, 792, 10.2106/00004623-200704000-00014
Darouiche, 1999, A comparison of two anti-microbial-impregnated central venous catheters, New Eng. J. Med., 340, 1, 10.1056/NEJM199901073400101
Falagas, 2007, Rifampicin-impregnated central venous catheters: A meta-analysis of randomized controlled trials, J. Antimicrob. Chemother., 59, 359, 10.1093/jac/dkl522
Schardey, 2003, Rifampicin and triclosan but not silver is effective in preventing bacterial infection of vascular Dacron graft material, Eur. J. Vasc. Endovasc. Surg., 26, 550, 10.1016/S1078-5884(03)00344-7
Halton, 2010, Cost-effectiveness of a central venous catheter care bundle, PloS ONE, 5, e12815, 10.1371/journal.pone.0012815
Walder, 2002, Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: Evidence from a meta-analysis, Infect. Control Hosp. Epidemiol., 23, 748, 10.1086/502005
Boelens, 2000, Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages, J. Infect. Dis., 181, 1337, 10.1086/315369
Broekhuizen, 2007, Peri-implant tissue is an important niche for Staphylococcus epidermidis in experimental biomaterial-associated infection in mice, Infect. Immun., 75, 1129, 10.1128/IAI.01262-06
Ceri, 2010, Needed, new paradigms in antibiotic development, Expert Opin. Pharmacother., 11, 1233, 10.1517/14656561003724747
Lohda, 2008, Prophylactic antibiotics in the prevention of catheter-associated bloodstream bacterial infection in preterm neonates: A systematic review, J. Perionatol., 28, 526, 10.1038/jp.2008.31
Alexander, 2009, History of the medical use of silver, Surg. Infect., 10, 289, 10.1089/sur.2008.9941
Spear, 2010, Silver: An age-old treatment modality in modern times, Plast. Surg. Nurs., 30, 90, 10.1097/PSN.0b013e3181deea2e
Atiyeh, 2007, Effect of silver on burn wound infection and healing: Review of the literature, Burns, 33, 139, 10.1016/j.burns.2006.06.010
Silver, 2006, Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds, J. Ind. Microbiol. Biotechnol., 33, 627, 10.1007/s10295-006-0139-7
Klasen, 2000, Historical review of the use of silver in the treatment of burns. I. Early uses, Burns, 26, 117, 10.1016/S0305-4179(99)00108-4
Klasen, 2000, A historical review of the use of silver in the treatment o burns. II. Renewed interest for silver, Burns, 26, 131, 10.1016/S0305-4179(99)00116-3
Rai, 2009, Silver nanoparticles as a new generation of antimicrobials, Biotechnology Advances, 27, 76, 10.1016/j.biotechadv.2008.09.002
Nakane, 2006, New antiaxillary odour deodorant made with antimicrobial Ag-eolite (silver-exchanged zeolite), Int. J. Cosmet. Sci., 28, 299, 10.1111/j.1467-2494.2006.00322.x
Meakins, 2009, Silver and new technology: Dressings and devices, Surg. Infect., 10, 293, 10.1089/sur.2008.9942
Furno, 2004, Silver nanoparticles and polymeric medical devices: A new approach to prevention of infection?, J. Antimicrob. Chemother., 54, 1019, 10.1093/jac/dkh478
Johnston, 2010, A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity, Crit. Rev. Toxicol., 40, 328, 10.3109/10408440903453074
Dowsett, 2004, The use of silver-based dressing in wound care, Nurs. Stand., 19, 56, 10.7748/ns.19.7.56.s58
Vos, 2010, Topical silver for preventing wound infection, Cochrane Database Syst. Rev., 3, CD006478
Carter, 2010, Silver treatments and silver-impregnated dressings for the healing of leg wounds and ulcers: A systematic review and meta-analysis, J. Am. Acad. Dermatol., 63, 668, 10.1016/j.jaad.2009.09.007
Lo, 2009, The effectiveness of silver-releasing dressing in the management of non-healing wounds: A meta-analysis, J. Clin. Nurs., 18, 716, 10.1111/j.1365-2702.2008.02534.x
Woo, 2009, Review: Silver-releasing dressings improve healing and quality of life in patients with non-healing chronic wounds, Evid. Based Nurs., 12, 117, 10.1136/ebn.12.4.117
Gravante, 2009, Nanocrystalline silver, Reconstr. Surg. Burns, 63, 201
2004, Effects of an activated charcoal solver dressing on chronic wounds with no clinical signs of infection, J. Wound Care, 13, 419, 10.12968/jowc.2004.13.10.26685
Miller, 2010, A randomized-controlled trial comparing cadexomer iodine and nanocrystalline silver on the healing of leg ulcers, Wound Repair Regen., 18, 359, 10.1111/j.1524-475X.2010.00603.x
Gravante, 2010, A retrospective analysis of ambulatory burn patients: Focus on wound dressings and healing times, Ann. Rev. Coll. Surg. Engl., 92, 118, 10.1308/003588410X12518836439001
Fichtner, 2010, Efficacy of silver-bearing external ventricular drainage catheters: A retrospective analysis, J. Neurosurg., 112, 840, 10.3171/2009.8.JNS091297
Lackner, 2008, Efficacy of silver-nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus, Neurocrit. Care., 8, 360, 10.1007/s12028-008-9071-1
Roe, 2008, Antimicrobial surface functionalization of plastic catheters by silver nanoparticles, J. Antimicrob. Chemther., 61, 869, 10.1093/jac/dkn034
Hsu, 2010, The biocompatibility and antibacterial properties of waterborne polyurethane-silver nanocomposites, Biomaterials, 31, 6796, 10.1016/j.biomaterials.2010.05.015
McCann, 2010, Interventions for preventing infectious complications in haemodialysis patients with central venous catheters, Cochrane Database Syst. Rev., 1, CD006894
Gilbert, 2008, Effectiveness of impregnated central venous catheters for catheter related blood stream infection: A systematic review, Curr. Opin. Infect. Dis., 21, 325, 10.1097/QCO.0b013e3282ffd6e0
Jaeger, 2005, Reduction of catheter-related infections in neutropenic patients: A prospective controlled randomized trial using chlorohexidine and silver sulfadiazine-impregnated central venous catheter, Ann. Hematol., 84, 258, 10.1007/s00277-004-0972-6
Rupp, 2005, Effect of a second-generation venous catheter impregnated with chlorohexidine and silver sulfadiazine on central catheter-related infections, Ann. Intern. Med., 143, 570, 10.7326/0003-4819-143-8-200510180-00007
Khare, 2007, Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central venous catheter in adult critical care, J. Infect., 54, 146, 10.1016/j.jinf.2006.03.002
Kaflon, 2007, Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients, Crit. Care Med., 35, 1032, 10.1097/01.CCM.0000259378.53166.1B
Johnson, 2006, Systematic review: Antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients, Ann. Intern. Med., 144, 116, 10.7326/0003-4819-144-2-200601170-00009
Trautner, 2010, Management of catheter-associated urinary tract infection, Curr. Opin. Infect. Dis., 23, 76, 10.1097/QCO.0b013e328334dda8
Seymour, 2006, Audit of catheter-associated UTI using silver alloy-coated Foley catheters, Br. J. Nurs., 15, 598, 10.12968/bjon.2006.15.11.21227
Parker, 2009, Nursing interventions to reduce the risk of catheter-associated urinary tract infection, J. Wound Ostomy Cont. Nurs., 36, 23, 10.1097/01.WON.0000345173.05376.3e
Liu, 2010, Controlled release of biologically active silver from nanosilver surfaces, ACS Nano, 4, 6903, 10.1021/nn102272n
Pallavicini, 2010, Self-assembled monolayers of silver nanoparticles firmly grafted on glass surfaces: Low Ag+ release for an efficient antibacterial activity, J. Colloid Interface Sci., 350, 110, 10.1016/j.jcis.2010.06.019
Safdar, 2002, A review of risk factors for catheter-related bloodstream infection caused by percutaenously inserted, noncuffed central venous catheters, Medicine, 81, 466, 10.1097/00005792-200211000-00007
Gordon, 2010, Silver coordination polymers for the prevention of implant infection: Thiol interaction, impact on respiratory chain enzymes and hydroxyl radical induction, Antimicrob. Agents Chemother., 54, 4208, 10.1128/AAC.01830-09
Pal, 2007, Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticles? A study of the gram-negative bacterium Eschericia coli, Appl. Environ. Microbiol., 73, 1712, 10.1128/AEM.02218-06
Panacek, 2006, Silver colloid nanoparticles: Synthesis, characterization, and their antibacterial activity, J. Phys. Chem. B, 110, 16248, 10.1021/jp063826h
Sotiriou, 2010, Antibacterial activity of nanosilver ions and particles, Environ. Sci. Technol., 44, 5649, 10.1021/es101072s
Lok, 2007, Silver nanoparticles: Partical oxidation and antibacterial activities, J. Biol. Inorg. Chem., 12, 527, 10.1007/s00775-007-0208-z
Danscher, 2010, In vivo liberation of silver ions from metallic silver surfaces, Histochem. Cell. Biol., 133, 359, 10.1007/s00418-009-0670-5
Ho, 2010, Oxidative dissolution of silver nanoparticles by biologically relevant oxidants: A kinetic and mechanistic study, Chem. Asian J., 5, 285, 10.1002/asia.200900387
Sondi, 2004, Silver nanoparticles as antimicrobial agent: A case on E. coli as a model for gram-negative bacteria, J. Colloid Interface Sci., 275, 177, 10.1016/j.jcis.2004.02.012
Mayr, 2009, Argyria and decreased kidney function: Are silver compounds toxic to the kidney?, Am. J. Kidney Dis., 53, 890, 10.1053/j.ajkd.2008.08.028
Asharani, 2009, Cytotoxicity and genotoxicity of silver nanoparticles in human cells, ACS Nano, 3, 279, 10.1021/nn800596w
Danilczuk, 2006, Conduction electron spin resonance of small silver particles, Spectrochim. Acta A, 63, 189, 10.1016/j.saa.2005.05.002
Kim, 2007, Antimicrobial effects of silver nanoparticles, Nanomed. Nanotechnol. Biol. Med., 3, 95, 10.1016/j.nano.2006.12.001
Silver, 2003, Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds, FEMS Microbiol. Rev., 27, 341, 10.1016/S0168-6445(03)00047-0
Percival, 2005, Bacterial resistance to silver in wound care, J. Hosp. Infect., 60, 1, 10.1016/j.jhin.2004.11.014
Cuin, 2007, Synthesis, X-ray structure and antimycobacterial activity of silver complexes with α-hydroxycarboxylic acids, J. Inorg. Biochem., 101, 291, 10.1016/j.jinorgbio.2006.10.001
Drake, 2005, Exposure-related health effects of silver and silver compounds: A review, Ann. Occup. Hyg., 49, 575
Ah, 2008, Occupational generalized argyria after exposure to aerosolized silver, J. Dermatol., 35, 759, 10.1111/j.1346-8138.2008.00562.x
Kwon, 2009, A case of argyria following colloidal silver ingestion, Ann. Dermatol., 21, 308, 10.5021/ad.2009.21.3.308
Hau, 2009, Presumed corneal argyrosis from occlusive soft contact lenses: A case report, Cornea, 28, 703, 10.1097/ICO.0b013e31818f9724
Wang, 2009, Silver deposits in cutaenous burn scar tissue is a common phenomenon following application of a silver dressing, J. Cutan. Pathol., 36, 788, 10.1111/j.1600-0560.2008.01141.x
Suska, 2010, In vivo evaluation of noble metal coatings, J. Biomed. Mater. Res. B Appl. Biomater., 92B, 86, 10.1002/jbm.b.31492
Asharani, 2009, Anti-proliferative activity of silver nanoparticles, BMC Cell Biol., 10, 65, 10.1186/1471-2121-10-65
Harter, 2002, Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy, Cancer, 94, 245, 10.1002/cncr.10199
Kakkos, 2008, Effectiveness of a new tunneled catheter in preventing catheter malfunction: A comparative study, J. Vasc. Interv. Radiol., 19, 1018, 10.1016/j.jvir.2008.03.006
Jansen, 1994, In vitro evaluation of the antimicrobial efficacy and biocomaptibility of a silver-coated central venous catheter, J. Biomater. Appl., 9, 55, 10.1177/088532829400900103
Kuter, 2004, Thrombotic complications of central venous catheters in cancer patients, Oncologist, 9, 207, 10.1634/theoncologist.9-2-207
Tenke, 2004, Bacterial biofilm formation on urological devices and heparin coating as preventive strategy, Int. J. Antimicrob. Agents, 23, S67, 10.1016/j.ijantimicag.2003.12.007
Cauda, 2008, Heparin coating on uretral double J stents prevents encrustations: An in vivo case study, J. Endourol., 22, 465, 10.1089/end.2007.0218
Zdanowski, 1997, Influence of heparin coating on in vitro bacterial adherence to poly(vinyl chloride) segments, J. Biomater. Sci. Polym. Ed., 8, 825, 10.1163/156856297X00029
Tang, 2007, Effect of surface modification of silicone on Staphylococcus epidermidis adhesion and colonization, J. Biomed. Mater. Res., 80A, 885, 10.1002/jbm.a.30952
Andersson, 2004, Antimicrobial activities of heparin-binding peptides, Eur. J. Biochem., 271, 1219, 10.1111/j.1432-1033.2004.04035.x
Malmsten, 2006, Bacterial killing by heparin-binding peptides from PRELP and thrombospondin, Matrix Biol., 25, 294, 10.1016/j.matbio.2006.04.003
Stevens, 2009, The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood, Biomaterials, 30, 3682, 10.1016/j.biomaterials.2009.03.054